Financhill
Sell
44

CVAC Quote, Financials, Valuation and Earnings

Last price:
$4.08
Seasonality move :
-18.91%
Day range:
$4.06 - $4.30
52-week range:
$2.22 - $5.28
Dividend yield:
0%
P/E ratio:
7.48x
P/S ratio:
1.54x
P/B ratio:
1.14x
Volume:
590.1K
Avg. volume:
993.9K
1-year change:
8.18%
Market cap:
$919.8M
Revenue:
$58.2M
EPS (TTM):
$0.55

Earnings Data

Next earnings date for CVAC
Apr 24
2025
Most recent earnings per share
$1.65
Beat by $0.11
(Nov 12/2024)
Consensus Estimate
$1.54
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CVAC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/24/2025 Q1 $14.3M -- -- -$0.18 --
12/31/2024 Q4 $6.9M -- -- -$0.13 --
11/12/2024 Q3 $150.6M $543.2M $1.65 $1.54 $0.11
08/15/2024 Q2 $5.4M $15.5M -$0.34 -$0.28 -$0.06
05/23/2024 Q1 $13.7M $13.4M -$0.34 -$0.22 -$0.11
12/31/2023 Q4 $31.5M $24.3M -$0.42 -$0.15 -$0.27
11/14/2023 Q3 -- -- -$0.24 -$0.23 -$0.01
08/17/2023 Q2 -- -- -$0.33 -$0.25 -$0.07
05/30/2023 Q1 -- -- -$0.29 -$0.37 $0.08
12/31/2022 Q4 -- -- -$0.70 -$0.29 -$0.41
09/30/2022 Q3 -- -- -$0.25 -$0.25 -$0.01
08/18/2022 Q2 -- -- -$0.33 -$0.33 -$0.00
05/25/2022 Q1 -- -- -$0.09 -- --
12/31/2021 Q4 -- -- -- -$0.98 --
11/19/2021 Q3 -- -- -$0.91 -- --
08/16/2021 Q2 -- -- -$0.99 -$1.01 $0.02
05/26/2021 Q1 -- -- -$0.75 -$0.92 $0.17
12/31/2020 Q4 -- -- -$0.38 -$0.61 $0.24
11/30/2020 Q3 -- -- -$0.24 -$0.88 $0.64
06/30/2020 Q2 -- -- -$0.06 -- --
03/31/2020 Q1 -- -- -$0.15 -- --
12/31/2019 Q4 -- -- -$0.23 -- --
09/30/2019 Q3 -- -- -$0.12 -- --
03/31/2019 Q1 -- -- -$0.14 -- --

CureVac NV Earnings Questions

  • How Much did CureVac NV Generate in Revenue Last Quarter?

    CureVac NV reported $543.2M worth of top line sales in its most recent quarter.

  • Did CureVac NV Beat Earnings Last Quarter?

    CureVac NV announced earnings per share of $1.65 which represents a beat of analyst forecast a $1.54 per share.

  • Is CureVac NV Profitable?

    CureVac NV reported $519.1M that represents $2.30 per share over the last quarter.

  • What is the Analyst Consensus for CureVac NV EPS Next Year?

    CureVac NV's earnings are forecast to decrease from -$1.28 per share to -$0.54 per share next year representing a decrease of -82.84%.

  • When is CureVac NV's Earnings Date?

    CureVac NV's next earnings date is April 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is AT&T Stock Dropping?
Why Is AT&T Stock Dropping?

The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…

Is American Express Stock Going Lower?
Is American Express Stock Going Lower?

American Express Company (NYSE:AXP) has long been a Buffett favorite…

Cigna vs Costco Stock: Which Is Best?
Cigna vs Costco Stock: Which Is Best?

Cigna and Costco don’t usually go hand in hand but…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 18

Quantum [QMCO] is down 15.61% over the past day.

Buy
51
QRVO alert for Jan 18

Qorvo [QRVO] is up 14.47% over the past day.

Sell
31
ATEX alert for Jan 18

Anterix [ATEX] is up 11.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock